Maternal serum insulin-like growth factor-binding protein-1 (IGFBP-1) at 11-13 weeks in pre-eclampsia

Prenatal Diagnosis

Volumn 31, Issue 2, 2011, Pages 196-201

  Sifakis, Stavros ^a   Akolekar, Ranjit ^b   Kappou, Dimitra ^a   Mantas, Nikitas ^b   Nicolaides, Kypros H ^b,c  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester screening; Insulin like growth factor binding protein 1; Pre eclampsia; Pregnancy associated plasma protein A; Uterine artery Doppler

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; OUTCOME ASSESSMENT; PATHOGENESIS; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PULSATILITY INDEX; UTERINE ARTERY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PULSE; UTERINE ARTERY;

EID: 79251493393     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2682     Document Type: Article

References (41)

1. ACOG Practice Bulletin. 2002. Diagnosis and management of preeclampsia and eclampsia. Number 33, 2002. ACOG Committee on Practice Bulletins-Obstetrics. Obstet Gynecol 99: 159-167.
2. Akolekar R, Syngelaki A, Sarquis R, Wright D, Nicolaides KH. 2011. Prediction of preeclampsia from biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 31(1): 66-74.
3. Anim-Nyame N, Hills FA, Sooranna SR, Steer PJ, Johnson MR. 2000. A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia. Hum Reprod 15: 2215-2219.
4. Aplin JD, Lacey H, Haigh T, Jones CJ, Chen CP, Westwood M. 2000. Growth factor-extracellular matrix synergy in the control of trophoblast invasion. Biochem Soc Trans 28: 199-202.
5. Baxter RC. 1995. Insulin-like growth factor binding proteins as glucoregulators. Metabolism 44: 12-17.
6. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. 2001. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20: IX-XIV.
7. D'Anna R, Baviera G, Corrado F, et al. 2006. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 113: 1264-1269.
8. de Groot CJ, O'Brien TJ, Taylor RN. 1996. Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia. Am J Obstet Gynecol 175: 24-29.
9. Forbes K, Westwood M. 2008. The IGF axis and placental function. Horm Res 69: 129-137.
10. Fowler DJ, Nicolaides KH, Miell JP. 2000. Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. Hum Reprod Update 6: 495-504.
11. Giudice LC, Irwin JC. 1999. Roles of the insulin-like growth factor family in nonpregnant human endometrium and at the decidual: trophoblast interface. Semin Reprod Endocrinol 17: 13-21.
12. Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. 1997. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 176: 751-757.
13. Gleeson LM, Chakraborty C, McKinnon T, Lala PK. 2001. Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein kinase pathway. J Clin Endocrinol Metab 86: 2484-2493.
14. Gratton RJ, Asano H, Han VK. 2002. The regional expression of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) in the placentae of women with pre-eclampsia. Placenta 23: 303-310.
15. Grobman WA, Kazer RR. 2001. Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia. Obstet Gynecol 97: 521-526.
16. Han VK, Bassett N, Walton J, Challis JR. 1996. The expression of insulin-like growth factor (IGF) and IGF binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab 81: 2680-2693.
17. Hietala R, Pohja-Nylander P, Rutanen EM, Laatikainen T. 2000. Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia. Obstet Gynecol 95: 185-189.
18. Ingec M, Gursoy HG, Yildiz L, Kumtepe Y, Kadanali S. 2004. Serum levels of insulin, IGF-I, and IGFBP-1 in pre-eclampsia and eclampsia. Int J Gynaecol Obstet 84: 214-219.
19. Irwin JC, Giudice LC. 1998. Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast alpha5beta1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. Growth Horm IGF Res 8: 21-31.
20. Irwin JC, Suen LF, Faessen GH, Popovici RM, Giudice LC. 2001. Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua: trophoblast interface during human implantation. J Clin Endocrinol Metab 86: 2060-2064.
21. Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34.
22. Jones JI, Gockerman A, Busby WH Jr, Wright G, Clemmons DR. 1993. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci U S A 90: 10553-10557.
23. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. 1995. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 85: 353-356.
24. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. 2008. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy associated plasma protein-A. Ultrasound Obstet Gynecol 31: 618-624.
25. Lacey H, Haigh T, Westwood M, Aplin JD. 2002. Mesenchymally-derived insulin-like growth factor 1 provides a paracrine stimulus for trophoblast migration. BMC Dev Biol 2: 5.
26. Lee PD, Giudice LC, Conover CA, Powell DR. 1997. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 216: 319-357.
27. Lewitt MS, Scott FP, Clarke NM, Wu T, Sinosich MJ, Baxter RC. 1998. Regulation of insulin-like growth factor-binding protein-3 ternary complex formation in pregnancy. J Endocrinol 159: 265-274.
28. Lorentzen B, Birkeland KI, Endresen MJ, Henriksen T. 1998. Glucose intolerance in women with pre-eclampsia. Acta Obstet Gynecol 77: 22-27.
29. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. 1994. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. BJOG 101: 669-674.
30. Monzavi R, Cohen P. 2002. IGFs and IGFBPs: role in health and disease. Best Pract Res Clin Endocrinol Metab 16: 433-447.
31. Ning Y, Williams MA, Vadachkoria S, Muy-Rivera M, Frederick IO, Luthy DA. 2004. Maternal plasma concentrations of insulin-like growth factor-1 and insulin-like growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia. Clin Biochem 37: 968-973.
32. Olausson H, Lof M, Brismar K, Lewitt M, Forsum E, Sohlstrom A. 2008. Longitudinal study of the maternal insulin-like growth factor system before, during and after pregnancy in relation to fetal and infant weight. Horm Res 69: 99-106.
33. Plascencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. 2007. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 30: 742-749.
34. Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. 2009. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 33: 23-33.
35. Rechler MM, Clemmons DR. 1998. Regulatory actions of insulin-like growth factor-binding proteins. Trends Endocrinol Metab 9: 176-183.
36. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH, Fetal Medicine Foundation First Trimester Screening Group. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 352: 343-346.
37. Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH. 2010. Maternal serum insulin-like growth factor-I at 11-13 weeks in preeclampsia. Prenat Diagn 30: 1026-1031.
38. Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH. 2006. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Ultrasound Obstet Gynecol 27: 658-663.
39. Thraikill KM, Clemmons DR, Busby WH Jr, Handwerger S. 1990. Differential regulation of insulin-like growth factor binding protein secretion from human decidual cells by IGF-I, insulin, and relaxin. J Clin Invest 86: 878-883.
40. Vatten LJ, Skjaerven R. 2004. Is pre-eclampsia more than one disease? BJOG 111: 298-302.
41. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH. 2005. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 193: 429-436.